ADVFN - Advanced Financial Network.
HOME» NASDAQ » I » ILMN Stock Price » ILMN Stock News

Illumina Share News

 Illumina (mm) Stock Price
ILMN Stock Price
 Illumina (mm) Stock Chart
ILMN Stock Chart
 Illumina (mm) Stock News
ILMN Stock News
 Illumina (mm) Company Information
ILMN Company Information
 Illumina (mm) Stock Trades
ILMN Stock Trades

Roche Sees No Reason To Raise Illumina Offer

ZURICH -(Dow Jones)- Swiss pharmaceutical giant Roche Holding AG (ROG.VX) Thursday said it sees "no reason whatsoever" to increase its offer for Illumina Inc. (ILMN) without entering talks with management at the U.S. gene-sequencing company. "Our offer of $51 is a full and fair offer and extremely attractive to Illumina shareholders," said Chief Executive Severin Schwan, on a conference call with analysts. Roche's preference remains for a negotiated deal with Illumina, Schwan said, but his company's approach has so far been rebuffed by Illumina's management, he added. "There is no reason whatsoever to increase our offer unless we get into negotiations. So far this is not the case," Schwan said. He was speaking as Roche, the world's biggest maker of cancer drugs, reported first-quarter sales of 11.03 billion Swiss francs ($12.09 billion), down 1% from a year earlier. -By John Revill, Dow Jones Newswires; +41 43 443 8042; [email protected]

Stock News for Illumina (ILMN)
DateTimeHeadline
01/19/201717:57:23Statement of Changes in Beneficial Ownership (4)
01/17/201706:30:00Illumina to Announce Fourth Quarter and Fiscal Year 2016 Financial...
01/12/201708:00:00Illumina, NRGene Collaborate to Accelerate Development of New...
01/11/201716:03:39Current Report Filing (8-k)
01/09/201719:10:00IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities...
01/09/201717:35:00Illumina and Bio-Rad Launch Solution for Single-Cell Genomic...
01/09/201717:30:00Illumina Introduces the NovaSeq Series—a New Architecture Designed t...
01/09/201709:00:00IBM and Illumina Partner to Standardize Genomic Data Interpretation
01/09/201708:45:00Philips and Illumina join forces to offer integrated genomics...
01/05/201716:05:00GRAIL Plans to Raise in Excess of $1B in Series B Funding
01/04/201710:22:00Leading Genetic Testing Companies Join Forces to Launch the Coalition...
01/03/201709:00:00Illumina Taps Garret Hampton, One of the World’s Leading Clinical G...
12/28/201622:00:00INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have...
12/27/201615:03:00ILMN LOSS NOTICE: Rosen Law Firm Reminds Illumina, Inc. Investors...
12/27/201606:30:00Illumina to Webcast Live Presentation at the J.P. Morgan Annual...
12/23/201615:22:00SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors...
12/20/201614:11:00SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On...
12/20/201614:02:00The Law Offices of Howard G. Smith Announces the Filing of a...
12/20/201609:00:00Illumina Names Jonathan Seaton as Senior Vice President for Corporate...
12/19/201621:23:00IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities...

Illumina and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US